Investigation of the Effectiveness of Prophylactic NPWT (ciNPWT) in High-risk Diabetic Patients With Acute Laparotomy Wounds

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorSemmelweis University

About this trial

The aim of this study is to evaluate the effectiveness of prophylactic Negative Pressure Wound Therapy (NPWT) in patients with diabetes mellitus undergoing laparotomy who are at high risk for Surgical Site Infections (SSI). In addition to clinical efficacy, the investigators also plan a cost effectiveness analysis to assess the applicability of this relatively high-cost intervention in a domestic healthcare setting.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years,

Undergoing urgent abdominal surgery,

Diagnosis of diabetes mellitus either already present or newly diagnosed at admission

High SSI risk. We consider a patient to be at high SSI risk if the operating surgeon categorizes the patient as high risk, and the patient is classified in the III-IV cleanliness category with an open abdominal surgical procedure (laparotomy). "High SSI risk" may also be assessed individually based on existing severe risk factors or using an SSI risk calculator (patients with a normal laparotomy SSI risk more than 3 times the baseline are eligible).

Disqualifiers

Pregnancy,

Disseminated cancer (irresectable distant metastasis, peritoneal carcinomatosis),

Life expectancy of less than 30 days,

Refusal to participate in the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Prophylactic/Incisional Negative Pressure Wound Therapy

    Device

    Negative Pressure Wound Therapy device used on closed laparotomy wound to prevent SSI.

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: ciNPWTExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Incidence of SSI

The ratio of patients developing surgical site infection after emergency laparotomy. Unit of Measure: Number and percentage of patients Measurement Tool : Clinical assessment and medical records

Time frame
30 days

Secondary outcomes

1

Length of Intensive Care Unit (ICU) stay

Number of days spent in the Intensive Care Unit following surgery. Unit of Measure: Days Measurement Tool: Hospital medical records

Time frame
30 days
2

Length of hospital stay

Total number of days of hospitalization following surgery. Unit of Measure: Days Measurement Tool: Hospital medical records

Time frame
30 days
3

Incidence of abdominal wall dehiscence

Occurrence of abdominal wall dehiscence following surgery. Unit of Measure: Number and percentage of patients Measurement Tool : Clinical assessment and medical records

Time frame
30 days
4

Reoperation rate

Proportion of patients requiring at least one reoperation following the index procedure. Unit of Measure: Number and percentage of patients (Yes/No) Measurement Tool: medical records

Time frame
30 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: